Illumina at TD Cowen Conference: Innovation and Growth Focus

On Tuesday, 03 March 2026, Illumina (NASDAQ:ILMN) presented its strategic vision at the TD Cowen 46th Annual Health Care Conference. CEO Jacob Thaysen underscored Illumina’s commitment to innovation and customer success, while addressing competitive pressures and financial challenges. Despite a premarket dip in stock price, the company remains optimistic about future growth, driven by advancements in sequencing technology and expansion into proteomics and spatial analysis.